Íomhá chlúdaigh

Indirect costs of the Rheumatoid arthritis in Poland

Taispeáin leaganacha eile (1)

It is estimated that about 400,000 people in Poland suffer from rheumatoid arthritis (RA). Only a few epidemiological studies documenting the incidence of musculoskeletal disorders in the Polish population have been conducted. The medical literature mainly states that rheumatoid arthritis affects ap...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Emilia Howoruszko (Údar), Szymon Szumiał (Údar), Aleksandra Izabela Czerw (Údar)
Formáid:	LEABHAR
Foilsithe / Cruthaithe:	Kazimierz Wielki University, 2019-05-01T00:00:00Z.
Ábhair:	article
Rochtain ar líne:	Connect to this object online.
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Indirect costs of the Rheumatoid arthritis in Poland
de réir: Emilia Howoruszko, et al.
Foilsithe / Cruthaithe: (2019)

Indirect costs of chronic N18 kidney disease in Poland
de réir: Martyna Koc, et al.
Foilsithe / Cruthaithe: (2019)

Indirect costs of chronic N18 kidney disease in Poland
de réir: Martyna Koc, et al.
Foilsithe / Cruthaithe: (2019)

Indirect costs of arterial hypertension and its complications
de réir: Anna Choromańska, et al.
Foilsithe / Cruthaithe: (2019)

Indirect costs of bronchial asthma and its complications
de réir: Żaneta Kieliszek, et al.
Foilsithe / Cruthaithe: (2019)

Indirect costs of arterial hypertension and its complications
de réir: Anna Choromańska, et al.
Foilsithe / Cruthaithe: (2019)

Indirect costs of bronchial asthma and its complications
de réir: Żaneta Kieliszek, et al.
Foilsithe / Cruthaithe: (2019)

Patient safety and performance of dietician profession in Poland
de réir: Marcin Mikos, et al.
Foilsithe / Cruthaithe: (2017)

Patient safety and performance of dietician profession in Poland
de réir: Marcin Mikos, et al.
Foilsithe / Cruthaithe: (2017)

Epidemiology and diagnostics of venous disease in Poland
de réir: Mateusz Curyło, et al.
Foilsithe / Cruthaithe: (2017)

Epidemiology and diagnostics of venous disease in Poland
de réir: Mateusz Curyło, et al.
Foilsithe / Cruthaithe: (2017)

Factors determining the financial effectiveness of outsourcing in medical entities in Poland
de réir: Mariola Borowska, et al.
Foilsithe / Cruthaithe: (2018)

Factors determining the financial effectiveness of outsourcing in medical entities in Poland
de réir: Mariola Borowska, et al.
Foilsithe / Cruthaithe: (2018)

Indirect costs and incidence of caregivers' short-term absenteeism in Poland, 2006-2016
de réir: Błażej Łyszczarz
Foilsithe / Cruthaithe: (2019)

Indirect costs and public finance consequences of heart failure in Poland, 2012-2015
de réir: Błażej Łyszczarz
Foilsithe / Cruthaithe: (2018)

The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland
de réir: Karolina Sobczyk, et al.
Foilsithe / Cruthaithe: (2023)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
de réir: Cynthia Said, et al.
Foilsithe / Cruthaithe: (2013)

Changes in the public health infrastructure in Poland in the context of an aging population
de réir: Monika Pajewska, et al.
Foilsithe / Cruthaithe: (2018)

Changes in the public health infrastructure in Poland in the context of an aging population
de réir: Monika Pajewska, et al.
Foilsithe / Cruthaithe: (2018)

Costs associated with rheumatoid arthritis in Italy: past, present, and future
de réir: Benucci M, et al.
Foilsithe / Cruthaithe: (2016)

The social cost of rheumatoid arthritis in Italy: the results of an estimation exercise
de réir: G. Turchetti, et al.
Foilsithe / Cruthaithe: (2014)

Diagnostics and physiotherapy in rheumatoid arthritis
de réir: Aleksandra Strońska, et al.
Foilsithe / Cruthaithe: (2021)

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
de réir: Vladimira V. Boyadzieva, et al.
Foilsithe / Cruthaithe: (2018)

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
de réir: R. Ariza, et al.
Foilsithe / Cruthaithe: (2014)

Rheumatoid Arthritis
Foilsithe / Cruthaithe: (2022)

Rheumatoid arthritis
de réir: Yoshiya Tanaka
Foilsithe / Cruthaithe: (2020)

Rheumatoid Arthritis Treatment
Foilsithe / Cruthaithe: (2012)

Skin in rheumatoid arthritis and seronegative arthritis
de réir: Pragathi Sankineni, et al.
Foilsithe / Cruthaithe: (2019)

Rehabilitation in rheumatoid arthritis
de réir: Anna Golus, et al.
Foilsithe / Cruthaithe: (2018)

Rehabilitation in rheumatoid arthritis
de réir: Anna Golus, et al.
Foilsithe / Cruthaithe: (2018)

Early rheumatoid arthritis
de réir: P. Sarzi-Puttini, et al.
Foilsithe / Cruthaithe: (2011)

Rheumatoid arthritis and atherosclerosis
de réir: B. Seriolo, et al.
Foilsithe / Cruthaithe: (2003)

Leishmaniasis in rheumatoid arthritis
de réir: M. Cutolo, et al.
Foilsithe / Cruthaithe: (2011)

Biomarkers in Rheumatoid Arthritis
de réir: Vincent Goëb, et al.
Foilsithe / Cruthaithe: (2014)

Atherosclerosis in Rheumatoid Arthritis
de réir: Miguel A. González-Gay, et al.
Foilsithe / Cruthaithe: (2012)

Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era
de réir: Catay E, et al.
Foilsithe / Cruthaithe: (2012)

Rheumatoid Arthritis Etiology, Consequences and Co-Morbidities
Foilsithe / Cruthaithe: (2012)

Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies
de réir: S. Sajith Kumar, et al.
Foilsithe / Cruthaithe: (2022)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
de réir: Schlueter M, et al.
Foilsithe / Cruthaithe: (2019)

Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
de réir: Bindra J, et al.
Foilsithe / Cruthaithe: (2021)